Concepedia

Michael A. Stashko

MA

Statistics

Publications

40

Citations

2.2K

H-Index

29

Active since

1991

Affiliations

University of North Carolina at Chapel Hill(Current)

Abbott Fund

Emory University

Abbott (United States)

Children's Healthcare of Atlanta

Michael A. Stashko is an author at University of North Carolina at Chapel Hill specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1991–2024

40

Publications

40

Discovery of a Potent, Selective Protein Tyrosine Phosphatase 1B Inhibitor Using a Linked-Fragment Strategy

Bruce G. Szczepankiewicz, Gang Liu, Philip J. Hajduk et al. · Journal of the American Chemical Society · 2003 · 228 citations · Full text

, , +17

Aminopyridine-Based c-Jun N-Terminal Kinase Inhibitors with Cellular Activity and Minimal Cross-Kinase Activity

Bruce G. Szczepankiewicz, Christi Kosogof, Lissa T.J. Nelson et al. · Journal of Medicinal Chemistry · 2006 · 160 citations · Full text

, , +15

<b>UNC2025</b>, a Potent and Orally Bioavailable MER/FLT3 Dual Inhibitor

Weihe Zhang, Deborah DeRyckere, Debra M. Hunter et al. · Journal of Medicinal Chemistry · 2014 · 160 citations · Full text

, , +14

Nonsteroidal Selective Glucocorticoid Modulators:  the Effect of C-5 Alkyl Substitution on the Transcriptional Activation/Repression Profile of 2,5-Dihydro-10-methoxy-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines

Steven W. Elmore, Michael J. Coghlan, David D. Anderson et al. · Journal of Medicinal Chemistry · 2001 · 111 citations · Full text

, , +17

Nonsteroidal Selective Glucocorticoid Modulators:  The Effect of C-10 Substitution on Receptor Selectivity and Functional Potency of 5-Allyl-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinolines

Philip R. Kym, Michael E. Kort, Michael J. Coghlan et al. · Journal of Medicinal Chemistry · 2003 · 108 citations · Full text

, , +17

1–5 of 40